1cP-LSD
1cP-LSD (N1-(cyclopropylmethanoyl)-lysergic acid diethylamide) is an acylated derivative of lysergic acid diethylamide (LSD) developed by Synex Synthetics, which has been sold as a designer drug. In tests on mice it was found to be an active psychedelic with similar potency to 1P-LSD.[1]
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C24H29N3O2 |
| Molar mass | 391.515 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Legal status
Sweden's public health agency suggested classifying 1cP-LSD as a dangerous substance on December 18, 2019.[2]
See also
References
- Brandt SD, Kavanagh PV, Westphal F, Stratford A, Odland AU, Klein AK, et al. (March 2020). "Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD)". Drug Testing and Analysis. doi:10.1002/dta.2789. PMID 32180350.
- "Tjugotre ämnen föreslås klassas som narkotika eller hälsofarlig vara" [Twenty-three substances are proposed to be classified as drugs or dangerous goods] (in Swedish). Folkhälsomyndigheten. 18 December 2019.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.